Blood Glucose Monitoring Consumables Market - Global Outlook and Forecast 2021-2026

Blood Glucose Monitoring Consumables Market - Global Outlook and Forecast 2021-2026

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Blood Monitoring Consumables Market Report

The global blood glucose monitoring consumables market by revenue is expected to grow at a CAGR of over 13% during the period 2020–2026.

The market has witnessed significant growth due to the growing prevalence of diabetes and the increasing awareness of self-management of diabetes. The prevalence of diabetes worldwide increases at an alarming rate due to changing lifestyles, growing alcohol consumption, and increasing smokers. However, the outbreak of the COVID-19 pandemic and the introduction of advanced test strips and lancets influence the digital diabetes management market's growth. The increased demand for self-care/homecare devices is also contributing to the usage of BGM consumables. With an increase in the sale of blood glucose meters, test strips, and lancets, the market offers tremendous growth opportunities for global, regional, and local vendors. Therefore, many vendors strategically focus on the development and commercial launches for regular blood glucose monitoring, which increases the demand for consumables.

The following factors are likely to contribute to the growth of the blood glucose monitoring consumables market during the forecast period:
COVID-19 Pandemic Increasing Demand for Test Strips & Lancets
Advances in Test Strip & Lancet Technology
High Availability of Generic Test Strips

The study considers the global glucose monitoring consumables market’s present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Global Blood Glucose Monitoring Consumables Market Segmentation
The global blood glucose monitoring consumables market research report includes a detailed segmentation by products, end-users, distribution channel, geography. Test strips accounted for over 64% of the global blood glucose monitoring consumables market in 2020. As revenues from test strips are recurring, vendors strategize to maximize sales volume and profit margins by offering innovative products. However, the growing use of self-monitoring blood glucose testing by patients and professionals in several POC testing sites such as emergency care, physician offices, ambulatory settings, and nursing homes increases test strips' consumption. Hospitals across the world have been using test strips for superfast output and nearly accurate results. These factors have increased the demand for test strips in the market.

In 2020, the end-user segment was segmented into individuals, hospitals and clinics, and others. The individuals segment accounted for the highest share of the market with 75%. The individual segment accounts for the highest share due to the wide acceptance of SMBG monitoring devices and consumables such as test strips, lancets, and lancing devices among consumers. The acceptance of these consumables and machines is confined to developed countries and in developing and underdeveloped countries, which has influenced their revenue growth. SMBG and CGM devices use sensors, lancets, lancing devices, and test strips as consumables to measure the blood glucose. The usage of CMBG is higher in developed countries such as the US and UK, France, Spain, Italy, and Germany due to the increased awareness of these devices and reimbursement options.

Online distribution channels are increasing significantly, although retail channels are maintaining their lead. Online purchasing channels expect to grow at a CAGR of over 12% during the forecast period. However, retail stores continue to be preferred for purchasing consumables and BGM devices in low- and middle-income countries. As the older generation patients prefer retail chains to purchase blood glucose consumables, the X generation prefers online channels for consumables due to high smartphone penetration. With the outbreak of the COVID-19 pandemic, most offline pharmacies were closed, which directly boosted consumables' sales via online channels. Hospital pharmacies, standalone pharmacies, and other retail pharmacies are the primary retail offline mode of distribution. Around 80% of BGM devices & consumables sales occur via retail channels in low- and middle-income countries.

Product
Test Strips
Lancets and Lancing Devices
Sensors
Distribution Channels
Offline
Online
End-users
Hospitals & Clinics
Individuals
Others

INSIGHTS BY GEOGRAPHY
In 2020, North America dominated the market due to its developed healthcare infrastructure and increased awareness of diabetics among patients. The usage of CGM sensors, test strips, lancets, and lancing devices is high among patients. The impact of COVID-19 has been increased in the region, with the US accounting for the highest infection rates.

Geography
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
APAC
China
India
Japan
South Korea
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Turkey
South Africa
Iran

INSIGHTS BY VENDORS
Medtronic, F. Hoffmann-La Roche, LifeScan, Abbott, and Ascensia are the major global players in the blood glucose consumables market. New product approvals/launches coupled with increased R&D activities are the major strategies implemented by vendors to expand presence, enhance market growth, and sustain the market position. Vendors are actively launching innovative devices to penetrate and tap the high growth potential of the market. Vendors are aggressively engaged in R&D activities and plan to launch several innovative products in the coming years. For instance, Abbott, F. Hoffmann-La Roche, Medtronic, Dexcom, LifeScan, and Ascensia Diabetes Care dominate the market due to continuous product innovations and launches. Several companies are developing or commercializing products such as CGM sensors with increased lifespan, advanced test strips, lancets, and lancing devices, respectively, for continuous and self-monitoring blood glucose devices in the market.

Prominent Vendors
Abbott
F. Hoffmann-La Roche
Dexcom
Medtronic
Ascensia Diabetes Care Holding
LifeScan

Other Prominent Vendors
77 Elektronika Kft
ARKRAY
A. Menarini Diagnostics
AgaMatrix
Alliance International
B. Braun Melsungen
Bionime
Bioptik
BioTest Medical
BTNX
EASYMAX
i-SENS
iHealth Lab
MED TRUST
Medisana
Major BioSystem
Sanofi
TaiDoc Technology
Terumo
Trividia Health
HMD
Rossmax International
Bioland Technology
e-Linkcare Meditech
Diagnosis SA
Microlife
Ypsomed
National Diagnostics Products
Norditalia
IME-DC

KEY QUESTIONS ANSWERED
1. What is the expected growth rate of the Global Blood Glucose Monitoring Consumables Market?
2. How big is the blood glucose test strips and lancet market?
3. What is the growth of the European blood glucose monitoring consumables market?
4. Who are the key vendors in the blood glucose consumables market?
5. Which segment accounted for the most significant blood glucose monitoring devices market share in 2020?


1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market by Product
4.3.2 Market by Distribution Channel
4.3.3 Market by End-user
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Increasing Demand for Test Strips & Lancets Due To COVID-19
8.2 Technological Advancements in Test Strips & Lancets
8.3 Availability of Large Number Of Generic Test Strips
9 Market Growth Enablers
9.1 Increasing Prevalence Of Diabetes
9.2 Increasing Vendor Focus On Recurring Revenue Through Consumables
9.3 Availability Of Wide Range Of Blood Glucose Monitoring Devices
10 Market Restraints
10.1 High Cost of Consumables & Lack Of Health Insurance
10.2 Presence of Large Undiagnosed Population
10.3 Increasing use Of Unauthorized & Counterfeit Test Strips
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product
11.2.2 Distribution Channel
11.2.3 End-User
11.2.4 Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Test Strips
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Test Strips: Geographical Segmentation
12.4 Lancets & Lancing Devices
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Lancets & Lancing Devices: Geographical Segmentation
12.5 CGM Sensors
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 CGM Sensors: Geographical Segmentation
13 Distribution Channel
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Online
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Online: Geographical Segmentation
13.4 Offline
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Offline: Geographical Segmentation
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Individuals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Individuals: Geographical Segmentation
14.4 Hospitals &Clinics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Hospitals & Clinics: Geographical Segmentation
14.5 Others
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Others: Geographical Segmentation
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product Segmentation
16.4 North America: Distribution Segemntation
16.5 North America: End-User Segmentation
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product Segmentation
17.4 Europe: Distribution Segmentation
17.5 Europe: End-User Segmentation
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 APAC: Product Segmentation
18.4 APAC: Distribution Segmentation
18.5 APAC: End-User Segemntation
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 India: Market Size & Forecast
18.6.4 South Korea: Market Size & Forecast
18.6.5 Australia: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product Segmentation
19.4 Latin America: Distribution Segmentation
19.5 Latin America: End-User Segmentation
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
19.6.3 Columbia: Market Size & Forecast
19.6.4 Argentina: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.4 Middle East & Africa: Distribution Channels
20.5 Middle East & Africa: End-User Segmentation
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 South Africa: Market Size & Forecast
20.6.3 Saudi Arabia: Market Size & Forecast
20.6.4 Iran: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.1.1 Abbott
21.1.2 F. Hoffmann-La Roche
21.1.3 Dexcom
21.1.4 Medtronic
21.1.5 Ascensia Diabetes Care Holdings
21.1.6 LifeScan
22 Key Company Profiles
22.1 Abbott
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 F. Hoffmann-La Roche
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Dexcom
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Medtronic
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 Ascensia Diabetes Care Holdings
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 Lifescan
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
23 Other Prominent Vendors
23.1 77 ELEKTRONIKA KFT.
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Arkray
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 A. Menarini Diagnostics
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Agamatrix
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Alliance International
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 B. Braun Melsungen
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Bionime
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Bioptik
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Biotest Medical
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 BTNX
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Easymax
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 I-SENS
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 IHealth Labs
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 MED Trust
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Medisana
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Major Biosystem
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 SANOFI
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Taidoc Technology
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Terumo
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Trividia Health
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Bioland Technology
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 Rossmax International
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 E-Linkcare Meditech
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 DIAGNOSIS S.A
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 Microlife
23.25.1 Business Overview
23.25.2 Product Offerings
23.26 HMD
23.26.1 Business Overview
23.26.2 Product Offerings
23.27 YPSOMED
23.27.1 Business Overview
23.27.2 Product Offerings
23.28 National Diagnostics Products
23.28.1 Business Overview
23.28.2 Product Offerings
23.29 Norditalia
23.29.1 Business Overview
23.29.2 Product Offerings
23.30 IME-DC
23.30.1 Business Overview
23.30.2 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market By Geography
25.2 Market By Product
25.2.1 Lancets & Lancing Devices
25.2.2 Test Strips
25.2.3 Sensors
25.2.4 North America: Product Segmentation
25.2.5 Europe: Product Segmentation
25.2.6 APAC: Product Segmentation
25.2.7 Latin America: Product Segmentation
25.2.8 Middle East & Africa: Product Segmentation
25.3 Market By End-User
25.3.1 Hospitals & Clinics
25.3.2 Individuals
25.3.3 Others
25.3.4 North America: End-user Segmentation
25.3.5 Europe: End-user Segmentation
25.3.6 APAC: End-user Segmentation
25.3.7 Latin America: End-user Segmentation
25.3.8 Middle East & Africa: End-user Segmentation
25.4 Market By Distribution Channel
25.4.1 Offline Distribution
25.4.2 Online Distribution
25.4.3 North America: Distribution Channel
25.4.4 Europe: Distribution Channel
25.4.5 APAC: Distribution Channel
25.4.6 Latin America: Distribution Channel
25.4.7 Middle East & Africa: Distribution Channel
26 Appendix
26.1 Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook